Normal immune function of monocyte-derived dendritic cells from HIV- infected individuals: Implications for immunotherapy

Journal of Immunology

Volumn 163, Issue 3, 1999, Pages 1666-1673

  Chougnet, Claire ^a   Cohen, Sandra S ^a   Kawamura, Tatsuyoshi ^a   Landay, Alan L ^b   Kessler, Harold A ^b   Thomas, Elaine ^c   Blauvelt, Andrew ^a   Shearer, Gene M ^a,d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c AMGEN INC   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD40 ANTIGEN; CD8 ANTIGEN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES;

ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION;

ADOPTIVE TRANSFER; ADULT; CELLS, CULTURED; CHEMOKINES; CYTOKINES; DENDRITIC CELLS; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MONOCYTES; T-LYMPHOCYTES;

EID: 0033179535     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Cella, M., F. Sallusto, and A. Lanzavecchia. 1997. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9:10.
2. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
3. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, K. C. Van, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263.
4. Adema, G. J., F. Hartgers, R. Verstraten, E. de Vries, G. Marland, S. Menon, J. Foster, Y. Xu, P. Nooyen, T. McClanahan, et al. 1997. A dendritic-cell derived C-C chemokine that preferentially attracts naive T cells. Nature 387:713.
5. Zagury, D., A. Lachgar, V. Chams, L. S. Fall, J. Bernard, J. F. Zagury, B. Bizzini, A. Gringeri, E. Santagostino, J. Rappaport, et al. 1998. Interferon α and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. Proc. Natl. Acad. Sci. USA 95:3851.
6. Schaniel, C., E. Pardali, F. Sallusto, M. Speletas, C. Ruedl, T. Shimizu, T. Seidl, J. Andersson, F. Melchers, A. G. Rolink, et al. 1998. Activated murine B lymphocytes and dendritic cells produce a novel CC chemokine which acts selectively on activated T cells. J. Exp. Med. 188:451.
7. + T cells. Science 57:383.
8. Pinchuk, L. M., P. S. Polacino, M. B. Agy, S. J. Klaus, and E. A. Clark. 1994. The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection. Immunity 1:317.
9. + T cells. J. Exp. Med. 182:2045.
10. Weissman, D., Y. Li, J. Ananworanich, L.-J. Zhou, J. Adelsberger, T. F. Tedder, M. Baseler, and A. S. Fauci. 1995. Three populations of cells with dendritic morphology exist in peripheral blood, only one of which is infectable with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 92:826.
11. Blauvelt, A., H. Asada, M. W. Saville, V. Klaus-Kovtun, D. J. Altman, R. Yarchoan, and S. I. Katz. 1997. Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through different pathways. J. Clin. Invest. 100:2043.
12. Knight, S. C., S. E. Macatonia, and S. Patterson. 1990. HIV-1 infection of dendritic cells. Int. Rev. Immunol. 6:163.
13. + T cells clonal expansion. Clin. Exp. Immunol. 88:226.
14. Blauvelt, A., M. Clerici, D. R. Lucey, S. M. Steinberg, R. Yarchoan, R. Walker, G. M. Shearer, and S. I. Katz. 1995. Functional studies of epidermal Langerhans cells and blood monocytes in HIV-infected persons. J. Immunol. 154:3506.
15. Blauvelt, A., C. Chougnet, G. M. Shearer, and S. I. Katz. 1996. Modulation of T cell responses to recall antigens presented by Langerhans cells in HIV-discordant identical twins by anti-interleukin (IL)-10 antibodies and IL-12. J. Clin. Invest. 97:1550.
16. Fan, Z., X.-L. Huang, L. Zheng, C. Wilson, L. Borowski, J. Liebmann, P. Gupta, J. Margolick, and C. Rinaldo. 1997. Cultured blood dendritic cells retain HIV-1 antigen-presenting capacity for memory CTL during progressive HIV-1 infection. J. Immunol. 159:4973.
17. Sapp, M., J. Engelmeyer, M. Larsson, A. Granelli-Piperno, R. Steinman, an N. Bhardwaj. 1999. Dendritic cells generated from blood monocytes of HIV-1 patients are not infected and act as competent antigen presenting cells eliciting potent T cell responses. Immunol. Lett. 66:121.
18. Canque, B., M. Rosenzwajg, S. Camus, M. Yagello, M. L. Bonnet, M. Guigon, and J. C. Gluckman. 1996. The effect of in vitro human immunodeficiency virus infection on dendritic-cell differentiation and function. Blood 88:4215.
19. + patients. AIDS Res. Hum. Retroviruses14:505.
20. Girolomoni, G., and P. Ricciardi-Castagnoli. 1997. Dendritic cells hold promise for immunotherapy. Immunol. Today 18:102.
21. Merrill, J. E., Y. Koyanagi, and I. S. Chen. 1989. Interleukin-1 and tumor necrosis factor α can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J. Virol. 63:4404.
22. Weiss, L., C. N. Haeffner, M. Laude, J. Gilquin, and M. D. Kazatchkine. 1989. HIV infection is associated with the spontaneous production of interleukin-1 (IL-1) in vivo and with an abnormal release of IL-1α in vitro. AIDS 3:695.
23. Birx, D. L., R. R. Redfield, K. Tencer, A. Fowler, D. S. Burke, and G. Tosato. 1990. Induction of interleukin-6 during human immunodeficiency virus infection. Blood 76:2303.
24. Esser, R., W. Glienke, R. Andreesen, R. E. Unger, M. Kreutz, H. Rubsamen-Waigmann, and H. von Briesen. 1998. Individual cell analysis of the cytokine repertoire in human immunodeficiency virus-1-infected monocytes/ macrophages by a combination of immunochemistry and in situ hybridization. Blood 91:4752.
25. Chehimi, J., S. E. Starr, I. Frank, A. D'Andrea, X. Ma, R. R. MacGregor, J. Sennelier, and G. Trinchieri. 1994. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 179:1361.
26. Chougnet, C., T. A. Wynn, M. Clerici, A. L. Landay, H. A. Kessler, J. Rusnak, G. P. Melcher, A. Sher, and G. M. Shearer. 1996. Molecular analysis of decreased IL-12 production in individuals infected with the human immunodeficiency virus. J. Infect. Dis. 174:46.
27. Harrison, T. S., and S. M. Levitz. 1997. Priming with IFN-γ restores deficient IL-12 production by peripheral blood mononuclear cells from HIV-seropositive donors. J. Immunol. 158:459.
28. Muller, F., P. Aukrust, E. Lien, C. J. Haug, and S. S. Froland. 1998. Enhanced interleukin-10 production in response to Mycobacterium avium products in mononuclear cells from patients with human immunodeficiency virus infection J. Infect. Dis. 1998:586.
29. Agarwal, S. K., and G. J. Marshall. 1998. In vivo alteration in type-1 and type-2 cytokine balance: a possible mechanism for elevated total IgE in HIV-infected patients. Hum. Immunol. 59:99.
30. Levy, J. K., J. W. Ritchey, J. B. Rottman, M. G. Davidson, Y. H. Liang, H. L. Jordam, W. A. Tompkins, and M. B. Tompkins. 1998. Elevated interleukin-10 to interleukin-12 ratio in feline immunodeficiency virus-infected cats predicts loss of type 1 immunity to Toxoplasma gondii. J. Infect. Dis. 178:503.
31. Fanslow, W. C., S. Srinivasan, R. Paxton, M. G. Gibson, M. K. Spriggs, and R. J. Armitage. 1994. Structural characteristics of CD40 ligand that determine biological function. Semin. Immunol. 6:267.
32. Berger, E. A., R. W. Doms, E. M. Fenyo, B. T. Korber, D. R. Littman, J. P. Moore, Q. J. Sattentau, H. Schuitemaker, J. Sodroski, and R. A. Weiss. 1998. A new classification for HIV-1. Nature 391:240.
33. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747.
34. de Saint-Vis, B., I. Fugier-Vivier, C. Massacrier, C. Gaillard, B. Vanbervliet, S. Ait-Yahia, J. Banchereau, Y.-J. Liu, S. Lebecque, and C. Caux. 1998. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J. Immunol. 160:1666.
35. Macatonia, S. E., R. Lau, S. Patterson, A. J. Pinching, and S. C. Knight. 1990. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology 71:38.
36. Gompels, M., S. Patterson, M. S. Roberts, S. E. Macatonia, A. J. Pinching, and S. C. Knight. 1998. Increase in dendritic cell numbers, their function and the proportion uninfected during AZT therapy. Clin. Exp. Immunol. 112:347.
37. Clerici, M., T. A. Wynn, J. A. Berzofsky, S. P. Blatt, C. W. Hendrix, A. Sher, R. L. Coffman, and O. M. Shearer. 1994. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J. Clin. Invest. 93:768.
38. Denis, M., and E. Ghadirian. 1994. Dysregulation of interleukin 8, interleukin 10, and interleukin 12 release by alveolar macrophages from HIV type 1-infected subjects. AIDS Res. Hum. Retroviruses 10:1619.
39. Chougnet, C., E. Thomas, A. L. Landay, H. A. Kessler, S. Buchbinder, S. Scheer, and G. M. Shearer. 1998. CD40 ligand and IFN-γ synergistically restore IL-12 production in HIV-infected patients. Eur. J. Immunol. 28:646.
40. Marshall, J. D., S. E. Robertson, G. Trinchieri, and J. Chehimi. 1997. Priming with IL-4 and IL-13 during HIV-1 infection restores in vitro IL-12 production by mononuclear cells of HIV-infected patients. J. Immunol. 159:5705.
41. Akridge, R. E., L. K. M. Oyafuso, and S. G. Reed. 1994. IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J. Immunol. 153:5782.
42. Dockrell, D., A. D. Badley, J. S. Villacian, C. J. Heppelman, A. Algeciras, S. Ziesmer, H. Yagita, D. H. Lynch, P. C. Roche, P. Leibson, et al. 1998. The expression of Fas ligand by macrophages and its up-regulation by human immunodeficiency virus infection. J. Clin. Invest. 101:2394.
43. Sartori, A., M. A. Oliveira, P. Scott, and G. Trinchieri. 1997. Metacyclogenesis modulates the ability of Leishmania promastigotes to induce IL-12 production in human mononuclear cells. J. Immunol. 159:2849.
44. von Stebut, E., Y. Belkaid, T. Jakob, D. L. Sacks, and M. C. Udey. 1998. Uptake of Leishmania major amastigotes results in activation and interleukin-12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J. Exp. Med. 188:1547.
45. Belkaid, Y., B. Butcher, and D. L. Sacks. 1998. Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells. Eur. J. Immunol. 8:1389.
46. Kombluth, R. S., K. Kee, and D. D. Richman. 1998. CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive β-chemokines. Proc. Natl. Acad. Sci. USA 95:5205.
47. Margolis, L. B., S. Glushakova, J. C. Grivel, and P. M. Murphy. 1998. Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines. J. Clin. Invest. 101: 1876.
48. Sallusto, F., P. Schaerli, P. Loetscher, C. Schaniel, D. Lenig, C. R. Mackay, S. Qin, and A. Lanzavecchia. 1998. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28:2760.
49. Moriuchi, M., H. Moriuchi, W. Turner, and A. S. Fauci. 1998. Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1. J. Clin. Invest. 102:1540.
50. Verani, A., G. Scarlatti, M. Comar, E. Tresoldi, S. Polo, M. Giacca, P. Lusso, A. G. Siccardi, and D. Vercelli. 1997. C-C chemokines released by Lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. J. Exp. Med. 185:805.
51. McDyer, J. F., M. Dybul, T. J. Goletz, A. L. Kinter, E. K. Thomas, J. A. Berzofsky, A. S. Fauci, and R. A. Seder. 1999. Differential effects of CD40 ligand/trimer stimulation on the ability of dendritic cells to transmit HIV infection: evidence for CC-chemokine dependent and -independent mechanisms. J. Immunol. 162:3711.
52. Dupuis, M., M. V. Peshwa, C. Benike, S. K. Kundu, G. Engleman, W. C. A. Van Schooten, and T. C. Merigan. 1997. Allogeneic dendritic cell induction of HIV-specific cytotoxic T lymphocyte responses from T cells of HIV type 1-infected and uninfected individuals. AIDS Res. Hum. Retroviruses 13:33.
53. Kundu, S. K., G. Engleman, C. Benike, M. H. Shapero, M. Dupuis, W. C. A. Van Schooten, M. Eibl, and T. C. Merigan. 1998. A pilot clinical trial of HIV antigen-pulsed allogeneic and autologous dendritic cell therapy in HIV-infected patients. AIDS Res. Hum. Retroviruses 14:551.
54. + T-helper and a T-killer cell. Nature 393: 474.
55. Bennett, S. R. M., F. R. Carbone, F. Karamalis, R. A. Flavell, J. F. A. P. Miller, and W. R. Heath. 1998. Help for cytotoxic T-cell responses is mediated by CD40 signalling. Nature 393:478.
56. Schoenberger, S. P., R. E. M. Toes, E. I. H. van der Voort, R. Offringa, and C. J. M. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480.